ID

39635

Beskrivning

Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1); ODM derived from: https://clinicaltrials.gov/show/NCT01963611

Länk

https://clinicaltrials.gov/show/NCT01963611

Nyckelord

Versioner (2)
  1. 2019-01-19 2019-01-19 -
  2. 2020-02-06 2020-02-06 - Christian Arras
Rättsinnehavare

EMD Serono

Uppladdad den

6 februari 2020

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Relapsing Remitting Multiple Sclerosis NCT01963611

Engelsk

Eligibility Relapsing Remitting Multiple Sclerosis NCT01963611

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, between the ages of 18 and 60 years
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
subject is able to learn and self-administer subcutaneous injections or a care-giver may be trained to inject the subject
Beskrivning

Subcutaneous injections, self-administration, ability | administration procedure, caregiver

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0021499
UMLS CUI [1,2]
C0036589
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C0021499
UMLS CUI [2,2]
C1533734
UMLS CUI [2,3]
C0085537
subjects must have a current diagnosis of relapsing remitting multiple sclerosis (rrms) (according to the 2010 mcdonald ms diagnostic criteria)
Beskrivning

Diagnosis of RRMS

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0751967
UMLS CUI [1,2]
C0679228
other protocol defined inclusion criteria could apply
Beskrivning

Inclusion criteria, Study protocol

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C2348563
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
any multiple sclerosis categorized as primary progressive, secondary progressive or progressive relapsing
Beskrivning

Multiple Sclerosis Primary Progressive, Multiple Sclerosis Secondary Progressive, Multiple Sclerosis Progressive Relapsing

Datatyp

boolean

Alias
UMLS CUI [1]
C0751964
UMLS CUI [2]
C0751965
UMLS CUI [3]
C0393666
allergy to mannitol, plovamer acetate, copaxone (glatiramer acetate), gd contrast for mri
Beskrivning

Hypersensitivity, Mannitol, Plovamer acetate, Copaxone, Gadolinium

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0024730
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C3272845
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0528175
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0016911
any requirement for continuous systemic glucocorticoid administration during the trial period.
Beskrivning

note: treatment with interferons such as avonex®, rebif®, or betaseron® will be allowed until the baseline visit, as no wash-out period is needed

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0744425
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C2347804
contraindication to copaxone use
Beskrivning

Contraindiction Copaxone

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0528175
other protocol defined exclusion criteria could apply
Beskrivning

Exclusion criteria

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C2348563
Tillbaka till toppen

Similar models

Eligibility Relapsing Remitting Multiple Sclerosis NCT01963611

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender, Age
Item
male or female, between the ages of 18 and 60 years
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Subcutaneous injections, self-administration, ability | administration procedure, caregiver
Item
subject is able to learn and self-administer subcutaneous injections or a care-giver may be trained to inject the subject
boolean
C0021499 (UMLS CUI [1,1])
C0036589 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0021499 (UMLS CUI [2,1])
C1533734 (UMLS CUI [2,2])
C0085537 (UMLS CUI [2,3])
Relapsing remitting multiple sclerosis, current diagnosis, McDonald diagnostic criteria
Item
subjects must have a current diagnosis of relapsing remitting multiple sclerosis (rrms) (according to the 2010 mcdonald ms diagnostic criteria)
boolean
C0751967 (UMLS CUI [1,1])
C0679228 (UMLS CUI [1,2])
Inclusion criteria, Study protocol
Item
other protocol defined inclusion criteria could apply
boolean
C1512693 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Multiple Sclerosis Primary Progressive, Multiple Sclerosis Secondary Progressive, Multiple Sclerosis Progressive Relapsing
Item
any multiple sclerosis categorized as primary progressive, secondary progressive or progressive relapsing
boolean
C0751964 (UMLS CUI [1])
C0751965 (UMLS CUI [2])
C0393666 (UMLS CUI [3])
Hypersensitivity, Mannitol, Plovamer acetate, Copaxone, Gadolinium
Item
allergy to mannitol, plovamer acetate, copaxone (glatiramer acetate), gd contrast for mri
boolean
C0020517 (UMLS CUI [1,1])
C0024730 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C3272845 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0528175 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0016911 (UMLS CUI [4,2])
Glucocorticoid therapy, Clinical trial period
Item
any requirement for continuous systemic glucocorticoid administration during the trial period.
boolean
C0744425 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
Contraindiction Copaxone
Item
contraindication to copaxone use
boolean
C1301624 (UMLS CUI [1,1])
C0528175 (UMLS CUI [1,2])
Exclusion criteria
Item
other protocol defined exclusion criteria could apply
boolean
C0680251 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial